natgillin/translations-raw huggingface dataset:
The clinical relevance of these findings is unknown (see section 5.3). 
Klinični pomen teh ugotovitev ni znan (glejte poglavje
Aminocaproic acid has an inhibitor effect on this system, which takes place on two levels: on the one hand, at relatively low concentrations, it inhibits the action of plasminogen activators by a competitive mechanism; on the other, at higher concentrations it inhibits plasmin activity. 
Aminokaprojska kislina ima zaviralni učinek na ta sistem, ki se odvija na dveh ravneh: po eni strani pri relativno nizkih koncentracijah zavira delovanje aktivatorjev plazminogena s kompetitivnim mehanizmom; po drugi strani pa pri višjih koncentracijah zavira aktivnost plazmina.
Rapid intravenous administration should be avoided, as it can cause hypotension, bradychardia and/or arrhythmias. 
Hitro intravensko infundiranje je treba preprečiti, saj lahko povzroči hipotenzijo, bradikardijo in/ali aritmije.
If any of these occur during administration of [Invented name] your doctor/surgeon will stop treatment with the drug. 
Če se med uporabo zdravila [Izmišljeno ime] pojavi kar koli od naštetega, bo vaš zdravnik/kirurg prenehal zdravljenje s tem zdravilom.
• skin rash with small, flat, red spots; 
• kožni izpuščaj z majhnimi, ploskimi, rdečimi pikami
Some patients have tolerated doses of up to 100 g, while cases of acute kidney failure have been described after a dose of 12 g. 
Nekateri bolniki so prenašali odmerke do 100 g, vendar so primere akutne odpovedi ledvic opisali že po odmerku 12 g.
• If bleeding is due to a condition called disseminated intravascular coagulation. 
• če je krvavitev posledica bolezni, imenovane diseminirana intravaskularna koagulacija.
It is widely distributed (it easily spreads to the tissues, appearing in semen, synovial fluid and foetal tissue) and it is excreted in urine, largely unaltered, with a terminal elimination half life of approximately 2 hours. 
Dobro se porazdeli (v tkivu se preprosto širi, pojavi se v spermi, sinovijski tekočini in tkivu zarodka) in se izloči s sečem, v veliki meri nespremenjena, s končnim razpolovnim časom približno 2 uri.
The most important affect the fibrinolytic enzyme system, the mechanism responsible for dissolving fibrin meshes and, therefore, clots. 
Najpomembnejši vplivajo na fibrinolitični encimski sistem, mehanizem, ki je odgovoren za raztapljanje fibrinskih mrežic in s tem strdkov.
Neurological effects 
Nevrološki učinki
Ask your doctor or pharmacist for advice before taking any medicine. 
Posvetujte se s svojim zdravnikom ali s farmacevtom, preden vzamete katero koli zdravilo.
• swelling of your eyelids, face, lips and tongue 
• otekanje vek, obraza, ustnic in jezika
If any of the side effects is serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 
Če kateri koli neželeni učinek postane resen ali če opazite kateri koli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
In case of dizziness or drowsiness, driving vehicles and using machines is not recommended. 
V primeru omotice ali dremavosti ni priporočljivo voziti avtomobila ali upravljati s stroji.
Thrombophlebitis, a possibility with all intravenous treatments, should be avoided, paying special attention to appropriate needle insertion and fixation. 
Tromboflebitis, do katerega lahko pride pri vseh intravenskih zdravljenjih, je treba preprečiti, ob čemer je treba posebno pozornost nameniti ustrezni vstavitvi in pritrditvi igle.
If you are pregnant, thinking about becoming pregnant or are breastfeeding, ask your doctor or pharmacist before starting this treatment. 
Če ste noseči, načrtujete zanositev ali dojite, se posvetujte s svojim zdravnikom ali farmacevtom, preden vzamete to zdravilo.
• decrease in blood pressure; 
• zmanjšanje krvnega tlaka
Aminocaproic acid should therefore not be administered in case of haematuria originating in the upper urinary tract unless the expected benefits more than exceed the risks. 
Aminokaprojske kisline se zato ne sme uporabiti v primeru hematurije, ki izvira v zgornjih sečilih, razen če so pričakovane koristi večje od tveganj.
Effects on ability to drive and use machines No studies have been conducted on the effects on the ability to drive and use machines. 
Vpliv na sposobnost vožnje in upravljanja s stroji Študij o vplivu na sposobnost vožnje in upravljanje s stroji niso izvedli.
Aminocaproic acid is not very toxic, so intoxication can only occur in very exceptional cases, such as in cases of relative overdose with kidney failure. 
Aminokaprojska kislina ni zelo toksična, zato se zastrupitev pojavi le v izjemno redkih primerih, kot na primer v primerih relativnega prevelikega odmerjanja z odpovedjo ledvic.
The most commonly reported adverse reactions during treatment are dizziness, hypotension and headache; hypotension is more likely to occur with rapid infusion. 
Neželeni učinki, o katerih so med zdravljenjem najpogosteje poročali, so omotica, hipotenzija in glavobol; bolj verjetno je, da se bo hipotenzija pojavila pri hitrem infundiranju zdravila.
Rapid infusion 
Hitro infundiranje
Warnings and precautions . 
Opozorila in previdnostni ukrepi
The administration of the equivalent to the maximum therapeutic dose in humans in the diet of rats caused fertility disorders in both sexes. 
Dajanje odmerka, ki pri ljudeh ustreza največjemu terapevtskemu odmerku, v prehrano podgan, je povzročilo motnje plodnosti pri obeh spolih.
Aminocaproic acid should not be used when there is evidence of an active intravascular clotting process (see section 4.4). 
Aminokaprojske kisline se ne sme uporabiti ob znakih aktivnega intravaskularnega strjevanja krvi (glejte poglavje 4.4).
• sudden shortness of breath or difficulty in breathing, sudden coughing for no apparent reason, chest pain and pain on breathing (as these may suggest a blood clot in the lungs), 
• nenadna kratka sapa ali težave z dihanjem, nenaden kašelj brez očitnega vzroka, bolečine v prsih in bolečine pri dihanju (to lahko nakazuje na krvni strdek v pljučih),
- Euglobulin clot test: abnormal in primary fibrinolysis and normal in DIC. 
- Evglobulinski test strjevanja: nenormalen pri primarni fibrinolizi in normalen pri DIK.
The following tests can be performed to distinguish between the two disorders: - Platelet count: it is usually reduced in DIC but not in primary fibrinolysis. 
Za razlikovanje med tema dvema motnjama so na voljo naslednji testi: - Število trombocitov: običajno je pri DIK zmanjšano, ne pa tudi pri primarni fibrinolizi.
The maximum daily dose should not exceed 24 g. 
Največji dnevni odmerek ne sme preseči 24 g.
Aminocaproic acid inhibits the effect of plasminogen activators and, to a lesser extent, plasmin activity. 
Aminokaprojska kislina zavira učinek aktivatorjev plazminogena in v manjšem obsegu tudi aktivnost plazmina.
• problems with bleeding or clotting, 
• težave s krvavitvijo ali strjevanjem
Serious cases of myopathy and rhabdomyolysis have been reported; these are generally reversible of discontinuation of treatment but CPK must be monitored in patients undergoing prolonged treatment and treatment stopped if any elevation in CPK occurs. 
Poročali so o resnih primerih miopatije in rabdomiolize; ti so običajno po prekinitvi zdravljenja reverzibilni, vendar je treba pri bolnikih, ki se zdravijo dalj časa, spremljati CPK in zdravljenje pri zvišanju ravni CPK takoj ustaviti.
However, the anti-haemorrhagic effect of aminocaproic acid is not necessarily linked to the presence of fibrinolysis in blood shown by the respective tests. 
Vendar pa antihemoragični učinek aminokaprojske kisline ni nujno povezan s prisotnostjo fibrinolize v krvi, kar kažejo zadevni testi.
• Talk to your doctor before you are given X:If you have poor kidney function. 
• Pred začetkom uporabe zdravila X se posvetujte s svojim zdravnikom: če imate okvarjeno delovanje ledvic,
• pain or skin death at the injection site 
• bolečina ali odmrla koža na mestu injiciranja
No treatment is known for overdose, although there is evidence that aminocaproic acid is eliminated by haemodialysis and can be eliminated by peritoneal dialysis. 
Za prevelik odmerek ni znanega zdravljenja, čeprav obstajajo dokazi, da se aminokaprojska kislina izloča s hemodializo in se lahko izloči s peritonealno dializo.
In this case, the medicinal product should be adjusted to the degree of kidney failure, or eventually be discontinued. 
V tem primeru je treba zdravilo prilagoditi ravni odpovedi ledvic ali uporabo prekiniti.
• significant bleeding induced by thrombolytic drugs; 
• močna krvavitev, ki jo povzročijo trombolitiki;
DATE OF REVISION OF THE TEXT [To be completed nationally 
DATUM ZADNJE REVIZIJE BESEDILA [izpolni država članica]
A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from aminocaproic acid therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman. 
Odločiti se je treba med prenehanjem dojenja in prenehanjem/prekinitvijo zdravljenja z aminokaprojsko kislino, pri čemer je treba pretehtati prednosti dojenja za otroka in prednosti zdravljenja za mater.
Aminocaproic acid is an amino acid that is structurally similar to other physiological amino acids, especially two fundamental amino acids, lysine and arginine. 
Aminokaprojska kislina je aminokislina s podobno strukturo kot druge fiziološke aminokisline, zlasti dve esencialni aminokislini, lizin in arginin.
Therapeutic indications 
Terapevtske indikacije
• unusual aches or pains in your muscles that go on for longer than you might expect (as these can result in kidney problems and potentially life-threatening muscle damage [rhabdomyolysis]) 
• neobičajne bolečine v mišicah, ki trajajo dlje, kot bi pričakovali (povzročijo lahko težave z ledvicami in potencialno življenjsko nevarno poškodbo mišic [rabdomiolizo])
• heavy menstrual periods; 
• močna menstrualna krvavitev;
Other side effects are: 
Drugi neželeni učinki:
The patient received 2 g of aminocaproic acid every 6 hours to make a total dose of 26 g. The patient died from prolonged cerebrovascular haemorrhage. 
Bolnik je vsakih 6 ur prejel 2 g aminokaprojske kisline v skupnem odmerku 26 g. Bolnik je zaradi dalj časa trajajoče cerebrovaskularne krvavitve umrl.
One case of heart and liver damage has been described in humans. 
Pri ljudeh je opisan en primer poškodb srca in jeter.
• dark-coloured urine, decreased amount or frequency of urine 
• seč temne barve, zmanjšana količina ali zmanjšana pogostnost izločanja seča
However, it should be administered with precaution in cases in which the existence of thrombosis or embolism is suspected, and in renal failure. 
Vendar pa jo je treba uporabiti previdno v primerih s sumom na obstoj tromboze ali embolije ter pri ledvični odpovedi.
In oral administration, the contents of the vial can be taken directly or mixed with a little sugar water, broth, milk, etc. 
Pri peroralnem načinu uporabe je mogoče vsebino viale vzeti neposredno ali jo primešati manjši količini sladkane vode, juhe, mleka itd.
Angioneurotic oedema 
Angionevrotski edem
Symptoms may include severe sore throat with high fever. 
Simptomi lahko vključujejo hudo vnetje grla s povišano telesno temperaturo.
If you use more <Aminocaproic acid-containing medicinal products> than you should If you take more <Aminocaproic acid-containing medicinal products> than you should, you may experience a sudden decrease in blood pressure (hypotension), with symptoms including dizziness, fainting, lightheadedness, blurred vision, a rapid, or irregular heartbeat (palpitations), confusion, feeling like you are going to be sick (nausea) or general weakness. 
Če uporabite več zdravila <zdravila, ki vsebujejo aminokaprojsko kislino>, kot bi smeli, lahko občutite naglo znižanje krvnega tlaka (hipotenzijo), s simptomi, ki vključujejo omotico, omedlevico, zamegljen vid, hitro ali nepravilno utripanje srca (palpitacije), zmedenost, občutek slabosti (navzeo) ali splošno oslabelost.
Inhibition of plasmin activity 
Zaviranje aktivnosti plazmina
However, there is no clear evidence that the administration of aminocaproic acid has been responsible for the few cases described of intravascular clotting after the treatment. 
Vendar pa ni jasnih dokazov, da je bilo dajanje aminokaprojske kisline odgovorno za nekaj primerov opisanega intravaskularnega strjevanja po zdravljenju.
If treatment needs to be extended, the maximum dose over 24 hours should not normally exceed 24 g. 
Če je treba zdravljenje podaljšati, največji odmerek običajno ne sme preseči 24 g v 24 urah.
The intravenous and oral lethal dose 50 of aminocaproic acid was 3 and 12 g/kg, respectively, in mice and 3.2 and 16.4 g/kg, respectively, in rats. 
Intravenski in peroralni smrtni odmerek 50 aminokaprojske kisline je bil pri miših 3 oz. 12 g/kg in pri podganah 3,2 oz. 16,4 g/kg.
The literature contains publications about an increased incidence of certain neurological deficits such as hydrocephaly, cerebral ischaemia or cerebral vasospasm associated to the use of antifibrinolytic agents in the treatment of subarachnoid haemorrhage (SAH). 
V literaturi so objave o povečani incidenci nekaterih nevroloških okvar, kot so hidrocefalus, cerebralna ishemija ali cerebralni vazospazem, povezani z uporabo antifibrinolitičnih zdravil pri zdravljenju subarahnoidne krvavitve (subarachnoid haemorrhage, SAH).
Numerous clinical studies show that aminocaproic acid has no thrombogenic effect. 
Številne klinične študije kažejo, da aminokaprojska kislina nima trombogenega učinka.
There is no need for dose adjustment in elderly patients. 
Pri starejših bolnikih odmerka ni treba prilagajati.
- Aminocaproic acid should not be used in DIC without the concomitant administration of heparin. 
- Aminokaprojske kisline se ne sme uporabiti pri DIK brez sočasne uporabe heparina.
The single dose of aminocaproic acid that produces overdose symptoms or considered to be life threatening is unknown. 
Primeri, ko bi en odmerek aminokaprojske kisline povzročil simptome prevelikega odmerjanja ali bil ocenjen kot življenjsko nevaren, niso znani.
Administration with Factor IX complex concentrate or anti-inhibitor clotting concentrates Aminocaproic acid should not be administered with Factor IX complex concentrate or anti-inhibitor clotting concentrates, as it could increase the risk of thrombosis. 
Dajanje s koncentratom faktorja IX ali koncentrati protizaviralcev strjevanja Aminokaprojske kisline se ne sme uporabiti s koncentratom faktorja IX ali s koncentrati protizaviralcev strjevanja, saj lahko to poveča tveganje za trombozo.
Aminocaproic acid has multiple pharmacological effects. 
Aminokaprojska kislina ima več farmakoloških učinkov.
• angioneurotic oedema (rapid swelling of the skin, mucosa and submucosal tissues). 
• angionevrotski edem (hitro otekanje kože, sluznice in podsluzničnega tkiva).
• bleeding from the lower urinary tract not caused by surgery (e.g. due to inflammation of the bladder); 
• krvavitev iz spodnjih sečil, ki ni posledica operacijea (npr. zaradi vnetja mehurja);
An intravenous dose of 2.3 g/kg was fatal in dogs. 
Pri psih je bil intravenski odmerek 2,3 g/kg smrten.
• gastroenterology 
• gastroenterološkem
It is unknown whether epsilon aminocaproic acid is excreted in human milk. 
Ni znano, ali se epsilon aminokaprojska kislina izloča v materino mleko.
Instead, it appears that said intravascular clotting was probably due to a pre-existing clinical condition, i.e. the presence of DIC. 
Nasprotno, kaže, da je intravaskularno strjevanje verjetno posledica obstoječega kliničnega stanja, tj. prisotnosti diseminirane intravaskularne koagulacije (DIK).
• a lumpy skin rash or ‘hives' anywhere on your body 
• izbokli kožni izpuščaj ali „koprivnico“ kjer koli na telesu
Like all medicines, aminocaproic acid can cause side effects, although not everybody gets them. 
Kot vsa zdravila ima lahko tudi aminokaprojska kislina neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
[If applicable] <[In oral administration, the content of the ampoule can be drunk as it is or mixed with a little sugared water, broth, milk, etc.]> 
[če je smiselno] <[Pri peroralnem načinu uporabe je mogoče vsebino ampule spiti ali jo primešati manjši količini sladkane vode, juhe, mleka itd.]>
- Protamine paracoagulation test: positive in DIC; a precipitate forms when a drop of protamine sulphate is added to “citrate” plasma. 
- Test protaminske parakoagulacije: pozitiven pri DIK; ko se kapljica protaminskega sulfata doda plazmi "citrata", nastane usedlina.
As a result of these effects, aminocaproic acid prevents clot destruction by plasmin and thus prevents the appearance of haemorrhages due to excessive fibrinolytic system activity. 
Kot rezultat teh učinkov aminokaprojska kislina plazminu prepreči uničevanje strdkov in s tem prepreči nastajanje krvavitev zaradi pretirane aktivnosti fibrinolitičnega sistema.
• heart surgery (with or without bypass placement) 
• na srcu (z namestitvijo obvoda ali brez)
6.4 Special precautions for storage [To be completed nationally] 
6.4 Posebna navodila za shranjevanje [Izpolni država članica]
• gynaecology (cervical surgery), in patients where tranexamic acid is not available or not tolerated 
• ginekološkem (poseg na materničnem vratu) pri bolnicah, ko traneksaminska kislina ni na razpolago ali je bolnica ne prenaša
The pharmacokinetic studies show that total body clearance of aminocaproic acid is highly diminished in patients with acute kidney failure. 
Farmakokinetične študije kažejo, da je popolni telesni očistek aminokaprojske kisline pri bolnikih z akutno odpovedjo ledvic močno zmanjšan.
If you have any further questions, ask your doctor. 
Če imate dodatna vprašanja, se posvetujte s svojim zdravnikom.
Elderly patients Dose reductions are not necessary other than in cases of kidney failure. 
Starejši bolniki Zmanjšanje odmerka ni potrebno, razen pri odpovedi ledvic.
Laboratory tests: the administration of aminocaproic acid can alter the results of platelet function tests. 
Laboratorijski testi: dajanje aminokaprojske kisline lahko spremeni rezultate testov delovanja trombocitov.
Establishing cause of haemorrhage When there are doubts regarding whether the aetiology of the haemorrhage which [Invented name] is being used to manage is primary fibrinolysis or disseminated intravascular clotting (DIC), this should be clarified before administering aminocaproic acid. 
Ugotavljanje vzroka za krvavitev Če obstajajo dvomi o tem, ali je za etiologijo krvavitve, za katero se zdravilo [Izmišljeno ime] uporablja, odgovorna primarna fibrinoliza ali diseminirana intravaskularna koagulacija (DIK), je treba to pred uporabo aminokaprojske kisline pojasniti.
Fibrinolysis inhibition by aminocaproic acid could theoretically result in clotting or thrombosis. 
Zaviranje fibrinolize, ki jo povzroči aminokaprojska kislina, lahko teoretično povzroči strjevanje ali trombozo.
One patient with a history of brain tumour and seizures presented seizures after receiving a bolus injection of 8 g of aminocaproic acid. 
Pri enem bolnik s tumorjem možganov in epileptičnimi napadi v anamnezi so se po bolusni injekciji 8 g aminokaprojske kisline pojavili epileptični napadi.
Aminocaproic acid is indicated for use in patients of all ages in haemorrhage caused by local or general fibrinolysis, including in Postsurgical haemorrhages in: 
Aminokaprojska kislina je indicirana za uporabo pri bolnikih vseh starosti s krvavitvami, ki jih povzroči lokalna ali splošna fibrinoliza, vključno za krvavitve po naslednjih kirurških posegih:
After intravenous administration, tonic-clonic seizures were observed in dogs and mice. 
Po intravenskem dajanju so pri psih in miših opazili tonično-klonične napade.
6.2 Incompatibilities [Invented name] should not be used with levulose solutions, solutions containing penicillin or with blood. 
Zdravila [Izmišljeno ime] ne uporabite z raztopino levuloze, raztopinami, ki vsebujejo penicilin ali s krvjo.
<Aminocaproic acid-containing medicinal products> is used to prevent blood loss due to excessive bleeding in patients of all ages. 
Zdravilo <zdravilo, ki vsebuje aminokaprojsko kislino,> se uporablja za preprečevanje izgube krvi zaradi močne krvavitve pri bolnikih vseh starosti.
• slow heart beat, 
• počasno bitje srca
Aminocaproic acid is rapidly absorbed when administered orally and its peak plasma concentrations are reached after two hours. 
Aminokaprojska kislina se po peroralni uporabi hitro absorbira in doseže največje koncentracije v plazmi po dveh urah.
The condition remits after administration is suspended; however, the syndrome may recur if the administration of aminocaproic acid is resumed. 
Stanje se po prekinitvi uporabe zdravila popravi, vendar pa se lahko sindrom pojavi znova, če se dajanje aminokaprojske kisline ponovno uvede.
Fertility, pregnancy and breast feeding 
Plodnost, nosečnost in dojenje
Marketing Authorisation Holder and Manufacturer [To be completed nationally] [See Annex I - To be completed nationally] {Name and address} <{tel}> <{fax}> <{e-mail}> 
Imetnik dovoljenja za promet z zdravilom in izdelovalec [Izpolni država članica] [Glejte Prilogo I - Izpolni država članica] {Ime in naslov} <{tel.}> <{faks}> <{e-pošta}>
Skeletal muscle effects 
Učinki na skeletne mišice
• postsurgical haemorrhages in urology (bladder and prostate surgery), gynaecology (surgery of the cervix), obstetrics (post-partum and post-abortion haemorrhage), cardiac surgery, gastroenterology, and odontostomatology (dental extractions in haemophiliacs and patients who are receiving anticoagulant therapy); 
• krvavitev po urološkem (operacija mehurja in prostate), ginekološkem (operacija materničnega vratu), porodniškem (krvavitev po porodu ali po splavu) kirurškem posegu, operaciji srca, gastroenterološkem in odontostomatološkem posegu (izruvanje zoba pri bolnikih s hemofilijo in bolnikih, ki prejemajo antikoagulante);
• odonto-stomatology (dental extractions in haemophiliacs, patients undergoing anticoagulant therapy) Life-threatening haemorrhages induced by thrombolytics (streptokinase, etc.). 
• odontostomatološkem (izruvanje zoba bolnikom s hemofilijo, bolnikom, ki se zdravijo z antikoagulanti) Življenjsko nevarne krvavitve, ki nastanejo zaradi trombolitikov (streptokinaze itd.).
What <Aminocaproic acid-containing medicinal product> is and what it is used for What you need to know before you take <Aminocaproic acid-containing medicinal products> 
Kaj je zdravilo <zdravilo, ki vsebuje aminokaprojsko kislino,> in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo <zdravilo, ki vsebuje aminokaprojsko kislino>
• If you are prone to the formation of thrombi (blood clots). 
• če ste nagnjeni k nastajanju trombov (krvnih strdkov),
Aminocaproic acid has been observed to give rise to teratogenic effects in rats. 
Opazili so, da aminokaprojska kislina povzroči teratogene učinke pri podganah.
Aminocaproic acid is not recommended during pregnancy. 
Aminokaprojske kisline ni priporočljivo uporabljati med nosečnostjo.
Very rare (affects less than 1 in 10,000 patients): 
Zelo redki (pojavijo se pri manj kot 1 od 10.000 bolnikov):
Intense menstruations, menorrhagia and haemorrhagic metropathies. 
Močne menstruacije, menoragija in hemoragične metropatije.
You may also uncommonly experience a decrease in white blood cells, which can increase the risk of infection. 
• kolaps (izgubo zavesti) Občasno se lahko pojavi tudi zmanjšanje števila belih krvnih celic, kar lahko poveča tveganje za okužbo.
CPK must be monitored in patients undergoing prolonged treatment. 
Pri bolnikih, ki se zdravijo dalj časa, je treba CPK nadzirati.
On rare occasions, skeletal muscle weakness with muscular fibre necrosis has been described after prolonged administration. 
V redkih primerih so po daljši uporabi opisali šibkost skeletnih mišic z nekrozo mišičnih vlaken.
• bleeding associated with thrombocytopenia (low platelets), thrombocytopenic purpura (bleeding disorder that affects the small vessels) or leukaemia; 
• krvavitev, povezana s trombocitopenijo (nizkim številom trombocitov), trombocitopenično purpuro (motnjo krvavitve, ki vpliva na majhne žile) ali levkemijo;